TMV's Knowledge Resource Centre Digital Repository

Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive

Show simple item record

dc.contributor.author Jadhav, Sanjay
dc.contributor.author Nalawade, Harshada
dc.date.accessioned 2021-10-14T09:11:42Z
dc.date.available 2021-10-14T09:11:42Z
dc.date.issued 2021-09
dc.identifier.citation Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive en_US
dc.identifier.issn 2581-9879
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/9975
dc.description.abstract Actually IP waiver was initiated with a proposal by India and South Africa at WTO at last year October 8.It was for a waiver on all covid-19 invention including testing as well as diagnostics under the conditions of trips agreement. Now it will take to remove intellectual property rights for vaccines should result in universal response to the current pandemic situation and way to tackle coming new variants of covid-19.Patent waiver on vaccines may create a barrier to share information for others for production of vaccines. en_US
dc.language.iso en en_US
dc.publisher Kesari Mahratta Trust en_US
dc.subject COVID-19 en_US
dc.subject Corona virus Pandemic en_US
dc.subject Patent waiver en_US
dc.title Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account